Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-011331
Filing Date
2022-06-08
Accepted
2022-06-08 16:25:55
Documents
51
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hlvx-20220331.htm   iXBRL 10-Q 2001307
2 EX-31.1 hlvx-ex31_1.htm EX-31.1 20675
3 EX-31.2 hlvx-ex31_2.htm EX-31.2 20639
4 EX-32.1 hlvx-ex32_1.htm EX-32.1 11948
5 EX-32.2 hlvx-ex32_2.htm EX-32.2 11924
  Complete submission text file 0000950170-22-011331.txt   6671438

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hlvx-20220331_def.xml EX-101.DEF 157430
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hlvx-20220331_lab.xml EX-101.LAB 367093
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hlvx-20220331_pre.xml EX-101.PRE 267265
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hlvx-20220331_cal.xml EX-101.CAL 29773
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hlvx-20220331.xsd EX-101.SCH 37386
45 EXTRACTED XBRL INSTANCE DOCUMENT hlvx-20220331_htm.xml XML 1059380
Mailing Address 75 STATE ST. SUITE 100 BOSTON MA 02109
Business Address 75 STATE ST. SUITE 100 BOSTON MA 02109 (617) 213-5054
HilleVax, Inc. (Filer) CIK: 0001888012 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41365 | Film No.: 221003822
SIC: 2836 Biological Products, (No Diagnostic Substances)